Eli Lilly (LLY) Shares Repurchased (2012 - 2026)

Eli Lilly (LLY) has 15 years of Shares Repurchased data on file, last reported at $2.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Shares Repurchased rose 96.33% year-over-year to $2.4 billion; the trailing twelve-month figure through Mar 2026 stood at $5.3 billion (up 42.27% YoY), and the FY2025 full-year result was $4.1 billion, up 64.32% from the prior year.
• Shares Repurchased for Q1 2026 stood at $2.4 billion, up from $1.5 billion in the prior quarter.
• Across five years, Shares Repurchased topped out at $2.4 billion in Q1 2026 and bottomed at $446.1 million in Q3 2024.
• The 5-year median for Shares Repurchased is $1.2 billion (2025), against an average of $1.2 billion.
• The widest annual swing landed in 2023, when Shares Repurchased tumbled 50.0%; it then surged 96.33% in 2026.
• A 5-year view of Shares Repurchased shows it stood at $1.5 billion in 2022, then sank by 50.0% to $750.0 million in 2023, then surged by 173.85% to $2.1 billion in 2024, then retreated by 26.59% to $1.5 billion in 2025, then soared by 56.26% to $2.4 billion in 2026.
• The last three Shares Repurchased figures came in at $2.4 billion (Q1 2026), $1.5 billion (Q4 2025), and $708.1 million (Q3 2025), per Business Quant data.

Peer Comparison